Literature DB >> 1439154

Growth regulatory functions of IL6 and antitumour effects.

M Revel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1439154     DOI： 10.1016/0923-2494(92)80021-c

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  6 in total

1.  Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells.

Authors:  I Delrieu; J C Faye; F Bayard; A Maret
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor.

Authors:  S Plaisance; W Vanden Berghe; E Boone; W Fiers; G Haegeman
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

3.  Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.

Authors:  Karina Galoian; Shihua Luo; Amir Qureshi; Parthik Patel; Rachel Price; Ashlyn S Morse; Gor Chailyan; Silva Abrahamyan; H T Temple
Journal:  Mol Clin Oncol       Date:  2016-09-02

4.  Analysis of IL6-protein complexes in chondrosarcoma.

Authors:  Karina Galoian; Shihua Luo; Parthik Patel
Journal:  Biomed Rep       Date:  2017-11-10

5.  In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

Authors:  W H Sun; J K Burkholder; J Sun; J Culp; J Turner; X G Lu; T D Pugh; W B Ershler; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.

Authors:  J M Stouthard; H Goey; E G de Vries; P H de Mulder; A Groenewegen; L Pronk; G Stoter; H P Sauerwein; P J Bakker; C H Veenhof
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.